Ourania Romanidou

Giannitsa, ESYE12, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Understanding exceptional response: The role of MINDY1 SNP in CDK4/6 inhibitor therapy for ER+, HER2- advanced breast cancer.

Understanding exceptional response: The role of MINDY1 SNP in CDK4/6 inhibitor therapy for ER+, HER2- advanced breast cancer.

Journal: HGG advances

Published: August 12, 2025

Molecular profile and clinical features of patients with gliomas using a broad targeted next generation-sequencing panel.

Molecular profile and clinical features of patients with gliomas using a broad targeted next generation-sequencing panel.

Journal: Oncology letters

Published: September 13, 2022

CHEK2 Pathogenic Variants in Greek Breast Cancer Patients: Evidence for Strong Associations with Estrogen Receptor Positivity, Overuse of Risk-Reducing Procedures and Population Founder Effects.

CHEK2 Pathogenic Variants in Greek Breast Cancer Patients: Evidence for Strong Associations with Estrogen Receptor Positivity, Overuse of Risk-Reducing Procedures and Population Founder Effects.

Journal: Cancers

Published: March 31, 2021

Is There an Independent Role of TERT and NF1 in High Grade Gliomas?

Is There an Independent Role of TERT and NF1 in High Grade Gliomas?

Journal: Translational oncology

Published: July 10, 2019

Bridging Cancer Biology with the Clinic: Comprehending and Exploiting IDH Gene Mutations in Gliomas.

Bridging Cancer Biology with the Clinic: Comprehending and Exploiting IDH Gene Mutations in Gliomas.

Journal: Cancer genomics & proteomics

Published: May 11, 2018

Overcoming resistance to first/second generation epidermal growth factor receptor tyrosine kinase inhibitors and ALK inhibitors in oncogene-addicted advanced non-small cell lung cancer.

Overcoming resistance to first/second generation epidermal growth factor receptor tyrosine kinase inhibitors and ALK inhibitors in oncogene-addicted advanced non-small cell lung cancer.

Journal: Therapeutic advances in medical oncology

Published: May 31, 2016

Management of NSCLC Disease Progression After First-Line EGFR Tyrosine Kinase Inhibitors: What Are the Issues and Potential Therapies?

Management of NSCLC Disease Progression After First-Line EGFR Tyrosine Kinase Inhibitors: What Are the Issues and Potential Therapies?

Journal: Drugs

Published: May 01, 2016

Therapies in the pipeline for small-cell lung cancer.

Therapies in the pipeline for small-cell lung cancer.

Journal: British medical bulletin

Published: April 13, 2016

The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer.

The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer.

Journal: BMC neurology

Published: October 13, 2015

EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab.

EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab.

Journal: Journal of cancer research and clinical oncology

Published: February 13, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026